Table 2 Recent trials of calcium channel blockers for chronic stable angina.
Study name | n | Patients studied | Treatment arms | Major findings |
---|---|---|---|---|
A Coronary disease Trial Investigating Outcome with Nifedipine (ACTION) | 3825 | Symptomatic, stable chronic angina, ambulatory, age 35 years, symptoms present ⩾1 month | GITS 60 mg vs placebo | 1. Safe: No ↑MI or CHF |
2. ↓Need for coronary angiography and PCI | ||||
Comparison of Amlodipine vs Enalapril to Limit Occurrences of Thrombosis (CAMELOT) | 1997 | Symptomatic patients requiring angiography for evaluation of chest pain, angiographically documented CAD, diastolic BP <100 mg Hg | Amlodipine 10 mg vs enalapril 20 mg vs placebo | 1. ↓Cardiovascular events |
2. ↓Progression of atherosclerosis as assessed by IVUS |
BP, blood pressure; CHF, congestive heart failure; GITS, gastrointestinal therapeutic system formulation of nifedipine; IVUS, intravascular ultrasound; MI, myocardial infarction; PCI, percutaneous coronary intervention.